Resources and support to guide reimbursement requests and help answer questions.
Syntactx/NAMSA, a confidential third-party Contract Research Organization (“CRO”), has been retained by the manufacturer of the Valiant Navion™ Thoracic Stent Graft System (Medtronic) to support patients confirmed to have been implanted with this product that was voluntarily recalled on February 17th, 2021.
Medtronic has developed a program to provide assistance to physicians and their patients patients who may be impacted by the product recall. The SAFE-N (Safety Assessment for Everyone-Navion) Program has several components, including: imaging and data collection, physician resources, and patient support.
Medtronic is committed to working with physicians and their patients to reduce financial barriers to recommended physician follow-up visits by helping to address unreimbursed recall-related medical expenses. Under this program, you may be eligible for reimbursement of out-of-pocket medical and incidental expenses for additional imaging and medical treatment that is directly related to the Valiant Navion Recall. Medtronic is offering a Limited Warranty to provide this support. Requests for reimbursement will be processed by Syntactx/NAMSA.
Please review the following information and contact Syntactx/NAMSA with any questions.
RE: SAFE-N Project 4 World Trade Center 150 Greenwich Street,
44th Floor New York, New York, 10007
Facsimile: 1 (800) 342-1401
|Country||Toll Free Number|
|India||+91 80005 02426|
|AUTHORIZATION FOR PATIENT CARE GIVER|
|LIMITED AUTHORIZATION TO DISCLOSE HEALTH INFORMATION|
|AUTHORIZATION TO DISCLOSE FINANCIAL INFORMATION|
|UNINSURED STATUS VERIFICATION FORM|